PolicyUpdates_5.14.20.pdf

QPP_COVID_SHMsummary

QPP Summary

SHM Buprenorphine Deregulation 2019 - Statement.pdf

The Society of Hospital Medicine supports the deregulation of buprenorphine to treat opioid use disorder. Buprenorphine is currently a Schedule III controlled substance but has restrictions

SHM Comments_MAPlans_PriorAuthorizationRFI.pdf

SHM Converge Newsletter.pdf

SHM Legislative Update - Summer 2019.pdf

Read SHM's Summer 2019 Grassroots Newsletter. Topics include: the Fairness for Highly Skilled Immigrants Act, the Conrad State 30 Re-authorization Act, the Mainstreaming Addiction Treatment Act,

SHM Submits Comments to CMS on FY2020 Hospital Prospective Payment System Proposed Rule.pdf

SHM Submits Comments to CMS on FY2020 Hospital Prospective Payment System Proposed Rule

Declining Personal Wellbeing.pdf

_blank

GapAssessment-SHM-PEC.xlsx

The Advisory Board Company’s Program Gap Assessment Tool _blank

KeyCharacteristics guide m1 WEB.pdf

Key Principles and Characteristics of An Effective Hospital Medicine Group _blank